Skip to main content

Heartbeam Inc(BEAT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.3500
Day High1.5100
Open:1.3800
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Heartbeam Inc

Select a category then submit the form to load news
Motley Fool
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript
Tipranks
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Tipranks
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences 
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Cresco Labs (CRLBF)
Tipranks
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
Tipranks
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
Tipranks
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target
Tipranks
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Tipranks
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
Tipranks
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer 
Tipranks
Analysts Offer Insights on Healthcare Companies: HeartBeam (BEAT) and Agios Pharma (AGIO)
Tipranks
Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB)
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
Tipranks
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
Investor Brand Network
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
Tipranks
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
Investor Brand Network
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
Tipranks
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
AllPennyStocks.com
Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring
Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring
Tipranks
Roth MKM Reaffirms Their Buy Rating on HeartBeam (BEAT)
Tipranks
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
Tipranks
HeartBeam (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology

Profile

HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.